查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847194

日本牙科移植骨替代物市場：市場規模、佔有率和趨勢分析（2025-2031）

Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | Japan | 2025-2031 | Includes: DBGSs, Dental Barrier Membranes, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 77 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年日本牙科移植骨替代物(DBGS) 和其他生醫材料市場價值約為 4,800 萬美元，預計到 2031 年將成長至近 7,100 萬美元。

本報告涵蓋牙科骨移植片、牙齒屏障膜、局部抗菌治療和牙軟組織傷口護理—統稱為牙科生醫材料市場。報告量化了銷售量、平均售價 (ASP)、市場價值、成長率和企業市場占有率。此外，報告還深入分析了市場促進因素和阻礙因素、併購活動、技術趨勢和競爭策略。報告提供了截至 2021 年的歷史數據和截至 2031 年的預測數據。

本研究詳細闡述了日本口腔保健體系和植入界如何影響再生牙科材料的使用。需求成長的促進因素包括：人工植牙手術的恢復、患者意識的提高，以及合成和異種移植生醫材料的進步，這些材料能夠支持可預測的骨整合和美學效果。

市場概覽

日本牙科生醫材料市場正處於穩定成長階段，臨床應用範圍不僅擴展到大學和醫院，也擴展到一般牙科診所。人們對植入成功率和修復體持久性的期望不斷提高，植入植入與骨再生手術之間的關聯也日益緊密。

  • 目前，合成移植材料是日本牙科生醫材料的主流。與異質骨移植相比，這些材料因其安全性高、易於取得且文化接受度更高而備受青睞。特別是，牛源性異質骨移植因其已證實的骨傳導能力和臨床療效，正逐漸佔市場佔有率。

異質骨移植的興起既反映了技術的進步，也體現了像蓋斯特利希（Geistlich）這樣的全球領先企業的影響力。蓋斯特利希憑藉其Bio-Oss®系列產品，持續引領移植材料性能的標竿。儘管人們對動物源性材料仍存在一些文化上的顧慮，但隨著教育計畫更加重視臨床數據和安全保障，臨床醫師的信心正在增強。

同時，日本牙科市場仍受到嚴格監管，進口商進口新型再生材料需要漫長的核准流程，減緩了競爭進入市場的速度。儘管如此，隨著植入市場逐漸擺脫先前的低迷形象，以及牙科旅遊業的蓬勃發展，國內外製造商都在加大對日本生醫材料領域的投資。

總體而言，儘管銷量保持穩定成長，但市場價值成長預計將來自適度的平均售價成長、不斷擴大的產品種類以及每次植入利用率的提高。

市場促進因素

人工植牙手術的成長

在日本，由於個別事件和有關病人安全的負面報道，人工植牙曾一度停滯數年，但如今正在復甦。植入手術的數量再次增加，尤其是在尋求固定修復方案而非活動假牙的老年人群中。每植入植入，都需要進行植骨手術，因此符合植骨手術條件的患者人數也穩定成長。

隨著植入在全科診所和小型診所的普及，人工牙根和異質骨移植都將受益。植入前增強骨強度對於成功的骨整合至關重要，人們對這項需求的認知也不斷提高。

提高消費者和從業人員的意識

在日本，教育計畫和牙科會議越來越重視再生牙科。製造商舉辦實務培訓課程，示範移植材料和屏障膜如何提高植入的長期穩定性。透過參與此類培訓，臨床醫生可以熟悉產品操作、滅菌標準和生物學特性，從而在使用異質骨移植和人工牙根時更加自信。

消費者的意識也在不斷提高。如今，選擇植入治療的患者期望骨骼和組織再生能夠成為綜合治療方案的一部分。這種以患者主導的需求正在推動高階材料的應用和市場接受度。

技術進步和產品多樣性

日本牙科生醫材料市場正受益於持續的產品創新。對疾病傳播的擔憂促使製造商開發先進的合成替代品，並加強同種異體移植材料的滅菌方法。改進的伽馬射線輻照和組織處理技術顯著降低了風險認知，從而提高了產品品質的穩定性並延長了保存期限。

製造商們也不斷最佳化屏障膜，以方便操作並縮短手術時間。例如，Geistlich公司的Bioguide Perio膜改進了表面結構，簡化了操作，提高了手術精度。日本國內企業，如GC株式會社，透過其合成碳酸鹽磷灰石基Cytrans®顆粒的類似創新，凸顯了日本在合成骨生醫材料領域的領先地位。

這些產品進步有助於提高平均售價，增強品牌差異化，並抵禦來自經銷商和公共採購的價格壓力。

市場限制

嚴格的法規環境

日本對醫用和牙科生醫材料的法律規範是世界上最嚴格的之一。企業必須在國內進行漫長的臨床試驗，產品才能註冊。這延緩了新生醫材料的上市，並增加了國內外供應商的成本。產品供應有限，減少了臨床醫師的選擇，也降低了短期內的市場競爭。

口腔健康狀況改善

日本全國範圍內的牙科預防舉措改善了各地的口腔健康指標。這一趨勢在惠及患者的同時，也減少了對大量修復性治療的需求。隨著拔牙和骨質流失發生率的下降，牙齒移植候選人數的成長速度可能低於人口老化所帶來的預期。

文化上對異種移植的反對

儘管牛和豬源移植材料在全球範圍內佔主導地位，但由於文化和宗教方面的敏感性，異質骨移植在日本尚未被廣泛接受。雖然像蓋斯特利希（Geistlich）這樣的歐洲製造商在過去幾年中取得了穩步進展，但部分患者和醫生的抵觸情緒仍然限制了異質骨移植領域的發展潛力，尤其是在屏障膜市場，動物源性膠原蛋白仍然是該領域的標準。

國內偷竊資源有限

由於運作的骨庫數量有限，日本國內的異體移植骨供應不足。因此，大部分骨移植骨需要從韓國和美國進口。高度的進口依賴，加上監管壁壘，導致價格居高不下，並限制了國內競爭。

整體而言，供應限制和監管摩擦仍然是加速市場成長的關鍵結構性挑戰。

目標市場和數據範圍

  • 量化指標：市場規模、市佔率、預測、成長率、銷售量、平均售價。
  • 定性內容：成長趨勢、市場限制、競爭分析、主要企業的 SWOT 分析、併購、公司組合、顛覆性技術、相關疾病概述。
  • 週期：基準年 2024 年，預測期間 2025-2031 年，歷史資料 2021-2023 年。
  • 資料來源：對日本牙科行業領導者的初步調查、政府和監管文件、私人醫院資料、進出口資料、iData Research 的專有資料庫。
  • 方法說明：收入以臨床使用率資料和經銷商輸入的檢驗單位數×平均售價計算。

治療場所包括日本各地的牙醫醫院、大學診所和私人牙科診所。

目標市場及區隔

牙科移植骨替代物（DBGS）市場

  • 用途包括齒槽窩保存、上顎竇加強、齒槽嵴加強和牙周病治療。
  • 依材料類型：同種異體移植、異質骨移植和合成材料。

牙科屏障膜市場

  • 依類型：可吸收、不可吸收。
  • 依材料分類：異種移植、合成。

抗菌牙周治療市場

含有用於治療牙周感染疾病和促進再生癒合的局部抗菌劑。

牙科軟組織傷口護理市場

  • 依類型：塞子、膠帶、泡棉。

僅對單元層面的區隔市場進行分析。

對每個區隔市場進行全面分析，涵蓋市場價值、平均售價、銷售量和預測成長率。

競爭分析

日本牙科生醫材料市場的競爭格局正在發生變化，國內外參與企業都在爭奪臨床市場佔有率。

2024年，蓋斯特利希製藥公司（Geistlich Pharma AG）超越長期佔市場領先地位的國內企業GC株式會社，成為市場領導。蓋斯特利希的成功得益於其強大的異質骨移植產品組合，其中以Bio-Oss®和Bio-Oss®膠原蛋白為核心，這兩款產品是全球骨再生領域的黃金標準。公司透過持續創新，鞏固了其在私人公司和機構牙科領域的市場地位，例如推出了一款50毫克規格的膠原蛋白產品，用於修復小缺損和進行輕微加固。

總部位於東京的GC株式會社排名第二。該公司優勢在於其合成DBGS產品和再生系統，這些產品符合日本對非動物源材料的偏好。其合成碳酸鹽磷灰石基Cytrans®骨移植材料是全球首創，展現了GC在材料科學領域的領先地位。此外，該公司還將移植材料與植入和CAD/CAM解決方案相結合，以支援完整的數位化牙科工作流程。

Envista Holdings Corporation 憑藉其在 2022 年對 Osteogenics Biomedical、Allotech 和 OBI Biologics 的收購，成為第三大競爭對手。這些收購擴大了該公司在牙科生醫材料的市場佔有率，尤其是在不可吸收膜領域。 Gore 公司 PTFE 膜產品退出亞太市場進一步拓展了 Envista 在日本的業務機會。

整體而言，競爭程度適中，但技術水準很高，市場佔有率集中在少數幾家跨國公司和國內公司手中，這促使企業持續投資於培訓、數位參與和研究合作。

技術與實務的趨勢

  • 合成優勢逐漸顯現，異種移植也逐漸被採用：隨著臨床醫生優先考慮臨床結果和操作特性，異質骨移植正在獲得越來越多的市場佔有率。
  • 先進的滅菌和組織處理：伽馬射線照射和增強的純化方法提高了材料的安全性和儲存穩定性。
  • 綜合再生系統：越來越多的製造商將包括骨移植、屏障膜和軟組織產品在內的再生解決方案捆綁在一起，以簡化採購和病例計劃。
  • 數位化植入規劃：CAD/CAM 和 3D 列印工作流程可實現更精確的植入體輪廓和客製化膜，從而支援微創技術。
  • 教育意義：植入和再生牙科的研究生培訓不斷擴大，加速了實證生醫材料的採用。
  • 永續性和在地採購：日本診所和經銷商正在尋求國內採購和環保包裝，以滿足新的採購標準。

這些因素共同造就了日本，使其成為牙科生醫材料領域技術最先進、文化最豐富的市場之一。

地區

本報告重點關注日本。

本報告的目的

日本牙科骨移植片和生醫材料市場中成長最快的機會是什麼？

異質骨移植、同種移植和合成材料在臨床上如何競爭？

日本嚴格的監管體系下，新產品進入市場的障礙是什麼？供應商如何克服這些障礙？

異質骨移植、膜和軟組織再生領域的關鍵參與者有哪些？

滅菌和加工技術的改進將如何影響產品差異化和定價？

成長面臨的風險有哪些？例如，人們對動物源性材料的文化抗拒以及口腔衛生狀況的改善？

當地企業如何調整其培訓計劃和行銷策略，以適應不斷變化的患者和臨床醫生的態度？

未來五年，日本的再生牙科將如何發展？其市場價值又將如何形塑？

iData Research 的「日本牙科骨移植片及其他生醫材料市場報告」透過基於流程的模型、企業市場占有率分析和定價數據來回答這些問題，以幫助您量化日本對牙科再生解決方案的需求，規劃您的產品發布，並製定您的定價和分銷策略。

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

日本牙科移植骨替代物及其他生醫材料市場

  • 摘要整理
    • 日本牙科移植骨替代物及其他生醫材料市場概覽
    • 競爭分析
    • 市場趨勢
    • 流程分段
    • 市場區隔
  • 介紹
    • 牙科骨移植替代物
    • 牙科屏障膜
    • 局部抗菌牙周治療
  • 手術次數
    • 齒槽骨移植手術
  • 計數分析
    • 依手術類型分類的牙科骨移植替代材料銷售情況
    • 牙科屏障膜單元（依尺寸）
  • 外匯
  • 市場概覽
  • 市場分析與預測
    • 牙科骨移植替代物市場
    • 牙科屏障膜市場
    • 抗菌牙周病治療市場
    • 牙科軟組織創傷護理市場
  • 推動和阻礙因素
  • 競爭市佔率分析
    • 牙科骨移植替代材料市場競爭格局分析
    • 牙科屏障膜市場競爭格局及市場佔有率分析
    • 抗菌牙周治療市場競爭市佔率分析

簡稱

Product Code: iDATA_JADBGS25_MS

The Japanese dental bone graft substitute (DBGS) and other biomaterials market was valued at nearly $48 million in 2024. It is projected to grow to reach almost $71 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care-collectively referred to as the dental biomaterials market. It quantifies units sold, average selling prices (ASPs), market values, growth rates, and company shares, while providing in-depth analysis of market drivers and limiters, mergers and acquisitions, technology trends, and competitive strategies. The report includes historical data to 2021 and forecasts to 2031.

The study provides a detailed view of how Japan's oral health system and its implantology community are influencing regenerative dental material usage. Demand is driven by the recovery of dental implant procedures, growing patient awareness, and advances in synthetic and xenograft biomaterials that support predictable osseointegration and aesthetic outcomes.

Market Overview

The Japanese dental biomaterials market is in a steady growth phase as clinical adoption broadens beyond university and hospital settings into general dental practices. Rising expectations for implant success rates and longer-lasting restorations have strengthened the link between implant placement and bone regeneration procedures.

  • Synthetic grafts currently dominate Japan's dental biomaterials landscape. These materials are favored for their safety profile, availability, and cultural acceptance compared to xenografts. However, the market has begun shifting: xenograft products, particularly those of bovine origin, are gradually capturing share due to their proven osteoconductive performance and clinical outcomes.

The shift toward xenografts reflects both technological advancements and the influence of global leaders like Geistlich, whose Bio-Oss(R) series continues to set the benchmark for graft performance. Despite lingering cultural hesitation toward animal-derived materials, clinician confidence is increasing as educational programs emphasize clinical data and safety assurance.

At the same time, Japan's dental market remains tightly regulated. Importers face lengthy approval timelines for new regenerative materials, which slows competitive entry. Nonetheless, as the implant market rebounds from earlier negative publicity and dental tourism strengthens, local and international manufacturers are re-investing in the Japanese biomaterials segment.

Overall, market value growth is expected to come from moderate ASP increases, expanded product variety, and higher utilization per implant procedure, even as unit volume growth remains stable.

Market Drivers

Growth of Dental Implant Procedures

Dental implant adoption in Japan has recovered after several years of stagnation caused by isolated patient safety incidents and negative media coverage. Implant surgery volumes are rising again, particularly among aging adults who seek fixed prosthetic solutions over removable dentures. Each implant placement increases the likelihood of a grafting procedure, creating a steady pool of patients eligible for DBGS use.

As implant penetration expands across general practices and smaller clinics, both synthetic and xenograft materials benefit. Bone quality enhancement prior to implant placement remains critical for successful osseointegration, and awareness of this requirement continues to grow.

Growing Consumer and Practitioner Awareness

Educational programs and dental conferences in Japan increasingly highlight regenerative dentistry. Manufacturers sponsor hands-on training that demonstrates how grafting materials and barrier membranes improve long-term implant stability. With this exposure, clinicians gain familiarity with product handling, sterilization standards, and biologic behavior, resulting in stronger confidence in using xenograft and synthetic options alike.

Consumer awareness is also increasing. Patients who invest in implant therapy now expect bone and tissue regeneration to be part of a comprehensive treatment plan. This patient-driven demand reinforces material adoption and premium product acceptance.

Technological Improvements and Product Variety

The Japanese dental biomaterials market benefits from continuous product innovation. Concerns about disease transmission have pushed manufacturers to develop advanced synthetic alternatives and to enhance allograft sterilization methods. The use of gamma irradiation and improved tissue processing has substantially reduced risk perception, enabling more consistent quality and longer shelf life.

Manufacturers are also optimizing barrier membranes for easier handling and reduced chair time. Geistlich's Bio-Gide(R) Perio, for example, was engineered with a modified surface structure to simplify manipulation and enhance accuracy during surgery. Similar innovation trends among domestic companies like GC Corporation-through its Cytrans(R) granules based on synthetic carbonate apatite-highlight Japan's leading role in synthetic bone biomaterials.

These product advancements support higher ASPs and strengthen brand differentiation, providing a buffer against pricing pressures from distributors and public procurement.

Market Limiters

Strict Regulatory Environment

Japan's regulatory framework for medical and dental biomaterials is among the most stringent globally. Companies must conduct lengthy domestic clinical trials before receiving product registration. This slows the introduction of new biomaterials and raises costs for both local and foreign suppliers. Limited product availability constrains choice for clinicians and dampens short-term competitive activity.

Improving Oral Health Outcomes

Nationwide preventive dentistry initiatives have improved oral health indicators across Japan. While this trend benefits patients, it reduces the need for extensive restorative procedures. As fewer extractions and bone defects occur, the total pool of grafting candidates may grow more slowly than the aging population would otherwise suggest.

Cultural Disapproval of Xenografts

Despite global dominance of bovine and porcine grafts, xenograft acceptance in Japan remains tempered by cultural and religious sensitivities. Although Geistlich and other European manufacturers have seen steady adoption in recent years, resistance from some patients and practitioners continues to limit the potential expansion of the xenograft segment-particularly in the barrier membrane market, where animal-derived collagen is standard.

Limited Supply of Domestic Allografts

Japan maintains only a few operational bone banks, restricting the availability of locally sourced allograft material. As a result, much of the supply is imported from South Korea and the United States. High import dependency and regulatory barriers combine to sustain premium prices and limit domestic competition.

Overall, supply constraints and regulatory friction remain the key structural challenges to faster market growth.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT profiles of leading players, mergers and acquisitions, company portfolios, disruptive technologies, and related disease overviews.
  • Time frame: Base year 2024; forecasts 2025 to 2031; historical data 2021 to 2023.
  • Data sources: Primary interviews with Japanese dental industry leaders, government and regulatory filings, private hospital data, import/export data, and iData Research's proprietary database.
  • Method note: Revenue is calculated as units X ASP, validated through clinical utilization data and distributor input.

Care settings include dental hospitals, university clinics, and private dental practices across Japan.

Markets Covered and Segmentation

Dental Bone Graft Substitute (DBGS) Market

  • By application: Socket preservation, sinus augmentation, ridge augmentation, periodontal.
  • By material type: Allograft, xenograft, synthetic.

Dental Barrier Membrane Market

  • By type: Resorbable, non-resorbable.
  • By material: Xenograft, synthetic.

Antimicrobial Periodontal Treatment Market

Includes local antimicrobial agents used to manage periodontal infections and support regenerative healing.

Dental Soft Tissue Wound Care Market

  • By type: Plugs, tape, foam.

Segment analyzed at the unit level only.

Each subsegment is analyzed with full coverage of market values, ASPs, units, and forecast growth.

Competitive Analysis

The competitive landscape in Japan's dental biomaterials market is evolving as both domestic and global players vie for clinical mindshare.

Geistlich Pharma AG emerged as the market leader in 2024, overtaking long-time domestic leader GC Corporation. Geistlich's success is anchored in its strong xenograft portfolio, led by Bio-Oss(R) and Bio-Oss(R) Collagen, considered the global gold standard for bone regeneration. The company's continuous innovation, including the 50 mg collagen variant for narrow defects and minor augmentations, has strengthened its position across both private and institutional dental sectors.

GC Corporation, headquartered in Tokyo, ranked second overall. Its strength lies in synthetic DBGS products and regenerative systems that align with Japan's preference for non-animal materials. The Cytrans(R) bone graft-based on synthetic carbonate apatite-is the first of its kind globally and demonstrates GC's leadership in material science. The company also integrates grafting materials with its implant and CAD/CAM solutions, supporting full digital dentistry workflows.

Envista Holdings Corporation became the third-largest competitor through its 2022 acquisition of Osteogenics Biomedical, Allotech, and OBI Biologics. This acquisition expanded its presence in dental biomaterials, particularly within the non-resorbable membrane category, a segment where Osteogenics had previously held a strong position. The withdrawal of Gore's PTFE membrane products from the Asia-Pacific market has further enhanced Envista's opportunity in Japan.

Overall, competition is moderate but technically sophisticated. Market share is concentrated among a few multinational and domestic players, encouraging continued investment in training, digital engagement, and research collaborations.

Technology and Practice Trends

  • Synthetic dominance with gradual xenograft adoption: While synthetics remain the majority, xenografts are gaining share as clinicians prioritize clinical outcomes and handling characteristics.
  • Advanced sterilization and tissue processing: Gamma irradiation and enhanced purification methods are improving material safety and shelf stability.
  • Integrated regenerative systems: Manufacturers increasingly offer bundled regenerative solutions that include bone grafts, barrier membranes, and soft tissue products to simplify procurement and case planning.
  • Digital implant planning: CAD/CAM and 3D printing workflows enable more precise graft contouring and custom membranes, supporting minimally invasive techniques.
  • Educational influence: Post-graduate training in implantology and regenerative dentistry continues to expand, accelerating adoption of evidence-based biomaterials.
  • Sustainability and local sourcing: Japanese clinics and distributors are exploring domestic sourcing and environmentally responsible packaging to meet new procurement standards.

These factors combine to make Japan one of the most technically progressive yet culturally nuanced markets for dental biomaterials globally.

Geography

This edition covers Japan.

Why This Report

Where is the fastest-growing opportunity within Japan's dental bone graft substitute and biomaterials market?

How are xenograft, allograft, and synthetic materials competing within clinical practice?

What are the barriers to new product entry under Japan's strict regulatory system, and how can suppliers navigate them?

Which companies are positioned to lead in xenografts, membranes, and soft tissue regeneration segments?

How do improvements in sterilization and processing technology affect product differentiation and pricing?

What are the risks to growth, including cultural resistance to animal-derived materials and improving oral health outcomes?

How can local and multinational companies align training programs and marketing with evolving patient and clinician awareness?

Where will regenerative dentistry in Japan evolve over the next five years, and how will this shape market value?

The Japan Dental Bone Graft Substitute and Other Biomaterials Market Report by iData Research answers these questions with procedure-aware models, company share analysis, and pricing data. Use it to quantify demand, plan product launches, and set pricing and distribution strategies for regenerative dental solutions in Japan.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Japan Dental Bone Graft Substitute and Other Biomaterials Market

  • 5.1 Executive Summary
    • 5.1.1 Japan Dental Bone Graft Substitute and Other Biomaterials Market Overview
    • 5.1.2 Competitive Analysis
    • 5.1.3 Market Trends
    • 5.1.4 Procedure Segmentation
    • 5.1.5 Market Segmentation
  • 5.2 Introduction
    • 5.2.1 Dental Bone Graft Substitutes
      • 5.2.1.1 Autografts
      • 5.2.1.2 Allografts
      • 5.2.1.2.1 Mineralized Allografts
      • 5.2.1.2.2 Demineralized Bone Matrix
      • 5.2.1.3 Xenografts
      • 5.2.1.4 Synthetics
    • 5.2.2 Dental Barrier Membranes
    • 5.2.3 Local Antimicrobial Periodontal Treatment
  • 5.3 Procedure Numbers
    • 5.3.1 Dental Bone Grafting Procedures
  • 5.4 Unit Analysis
    • 5.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
    • 5.4.2 Dental Barrier Membrane Units Sold by Size
      • 5.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
      • 5.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
  • 5.5 Currency Exchange Rate
  • 5.6 Market Overview
  • 5.7 Market Analysis and Forecast
    • 5.7.1 Dental Bone Graft Substitute Market
      • 5.7.1.1 Allograft Market
      • 5.7.1.2 Xenograft Market
      • 5.7.1.3 Synthetic Market
    • 5.7.2 Dental Barrier Membrane Market
      • 5.7.2.1 Dental Barrier Membrane Market by Segment
      • 5.7.2.1.1 Xenograft Dental Barrier Membrane Market
      • 5.7.2.1.2 Synthetic Dental Barrier Membrane Market
      • 5.7.2.2 Dental Barrier Membrane Market by Material
      • 5.7.2.2.1 Resorbable Dental Barrier Membrane Market
      • 5.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
    • 5.7.3 Antimicrobial Periodontal Treatment Market
    • 5.7.4 Dental Soft Tissue Wound Care Market
      • 5.7.4.1 Dental Wound Care Plugs Market
      • 5.7.4.2 Dental Wound Care Tape Market
      • 5.7.4.3 Dental Wound Care Foam Market
  • 5.8 Drivers and Limiters
    • 5.8.1 Market Drivers
    • 5.8.2 Market Limiters
  • 5.9 Competitive Market Share Analysis
    • 5.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
    • 5.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
    • 5.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 5-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, Japan, 2024
  • Chart 5-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, Japan, 2024 & 2031
  • Chart 5-3: Dental Bone Grafting Procedures by Segment, Japan, 2021-2031
  • Chart 5-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031
  • Chart 5-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Japan, 2024

LIST OF FIGURES

  • Figure 5-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, Japan, 2024
  • Figure 5-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan
  • Figure 5-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, Japan
  • Figure 5-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, Japan
  • Figure 5-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, Japan, 2021-2031
  • Figure 5-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, Japan, 2021-2031 (1 of 2)
  • Figure 5-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, Japan, 2021-2031 (2 of 2)
  • Figure 5-8: Dental Bone Graft Units Sold by Procedure, Japan, 2021-2031
  • Figure 5-9: Resorbable Dental Barrier Membrane Units Sold by Size, Japan, 2021-2031
  • Figure 5-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, Japan, 2021-2031
  • Figure 5-11: Currency Exchange Rate, 2024
  • Figure 5-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031 (US$M)
  • Figure 5-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031 (JP¥M)
  • Figure 5-14: Total Dental Bone Graft Substitute Market, Japan, 2021-2031
  • Figure 5-15: Dental Bone Graft Substitute Market by Segment, Japan, 2021-2031 (US$M)
  • Figure 5-16: Dental Bone Graft Substitute Market by Segment, Japan, 2021-2031 (JP¥M)
  • Figure 5-17: Xenograft Market, Japan, 2021-2031
  • Figure 5-18: Synthetic Market, Japan, 2021-2031
  • Figure 5-19: Total Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-20: Dental Barrier Membrane Market by Segment, Japan, 2021-2031 (US$M)
  • Figure 5-21: Dental Barrier Membrane Market by Segment, Japan, 2021-2031 (JP¥M)
  • Figure 5-22: Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-23: Bovine Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-24: Porcine Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-25: Synthetic Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-26: Dental Barrier Membrane Market by Material, Japan, 2021-2031 (US$M)
  • Figure 5-27: Dental Barrier Membrane Market by Material, Japan, 2021-2031 (JP¥M)
  • Figure 5-28: Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-29: Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-30: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-31: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
  • Figure 5-32: Total Antimicrobial Periodontal Treatment Market, Japan, 2021-2031
  • Figure 5-33: Dental Wound Care Market by Type, Japan, 2021-2031 (US$M)
  • Figure 5-34: Dental Wound Care Market by Type, Japan, 2021-2031 (JP¥M)
  • Figure 5-35: Dental Soft Tissue Wound Care Market, Japan, 2021-2031
  • Figure 5-36: Dental Wound Care Plugs Market, Japan, 2021-2031
  • Figure 5-37: Dental Wound Care Tape Market, Japan, 2021-2031
  • Figure 5-38: Dental Wound Care Foam Market, Japan, 2021-2031
  • Figure 5-39: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Japan, 2024
  • Figure 5-40: Leading Competitors, Dental Bone Graft Substitute Market, Japan, 2024
  • Figure 5-41: Leading Competitors, Dental Barrier Membrane Market, Japan, 2024
  • Figure 5-42: Leading Competitors, Antimicrobial Periodontal Treatment Market, Japan, 2024